Cargando…

Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure

Acute liver failure (ALF) is a rare entity but exhibits a high mortality. The mechanisms underlying ALF are not completely understood. The present study explored the role of the hepatic B cell leukemia-3 (Bcl-3), a transcriptional regulator of nuclear factor-kappa B (NF-κB), in two independent model...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehrke, Nadine, Wörns, Marcus A., Mann, Amrit, Hövelmeyer, Nadine, Waisman, Ari, Straub, Beate K., Galle, Peter R., Schattenberg, Jörn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156769/
https://www.ncbi.nlm.nih.gov/pubmed/35641486
http://dx.doi.org/10.1038/s41419-022-04946-y
_version_ 1784718505269002240
author Gehrke, Nadine
Wörns, Marcus A.
Mann, Amrit
Hövelmeyer, Nadine
Waisman, Ari
Straub, Beate K.
Galle, Peter R.
Schattenberg, Jörn M.
author_facet Gehrke, Nadine
Wörns, Marcus A.
Mann, Amrit
Hövelmeyer, Nadine
Waisman, Ari
Straub, Beate K.
Galle, Peter R.
Schattenberg, Jörn M.
author_sort Gehrke, Nadine
collection PubMed
description Acute liver failure (ALF) is a rare entity but exhibits a high mortality. The mechanisms underlying ALF are not completely understood. The present study explored the role of the hepatic B cell leukemia-3 (Bcl-3), a transcriptional regulator of nuclear factor-kappa B (NF-κB), in two independent models of ALF. We employed a recently developed transgenic mouse model in a C57BL6/J background comparing wild-type (WT) and transgenic littermates with hepatocyte-specific overexpression of Bcl-3 (Bcl-3(Hep)) in the ALF model of d-galactosamine (d-GalN) and lipopolysaccharide (LPS). Additionally, the apoptosis-inducing CD95 (FAS/APO-1)-ligand was explored. Bcl-3(Hep) mice exhibited a significant protection from ALF with decreased serum transaminases, decreased activation of the apoptotic caspases 8, 9, and 3, lower rates of oxidative stress, B-cell lymphoma 2 like 1 (BCL2L1/BCL-X(L)) degradation and accompanying mitochondrial cytochrome c release, and ultimately a decreased mortality rate from d-GalN/LPS compared to WT mice. d-GalN/LPS treatment resulted in a marked inflammatory cytokine release and stimulated the activation of signal transducer and activator of transcription (STAT) 3, c-Jun N-terminal kinases (JNK) and extracellular signal-regulated kinase (ERK) signaling comparably in the hepatic compartment of Bcl-3(Hep) and WT mice. However, in contrast to the WT, Bcl-3(Hep) mice showed a diminished rate of IkappaB kinase-beta (IKK-β) degradation, persistent receptor interacting protein kinase (RIPK) 1 function and thus prolonged cytoprotective nuclear factor-kappa B (NF-κB) p65 signaling through increased p65 stability and enhanced transcription. Likewise, Bcl-3 overexpression in hepatocytes protected from ALF with massive hepatocyte apoptosis induced by the anti-FAS antibody Jo2. The protection was also linked to IKK-β stabilization. Overall, our study showed that Bcl-3 rendered hepatocytes more resistant to hepatotoxicity induced by d-GalN/LPS and FAS-ligand. Therefore, Bcl-3 appears to be a critical regulator of the dynamics in ALF through IKK-β.
format Online
Article
Text
id pubmed-9156769
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91567692022-06-02 Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure Gehrke, Nadine Wörns, Marcus A. Mann, Amrit Hövelmeyer, Nadine Waisman, Ari Straub, Beate K. Galle, Peter R. Schattenberg, Jörn M. Cell Death Dis Article Acute liver failure (ALF) is a rare entity but exhibits a high mortality. The mechanisms underlying ALF are not completely understood. The present study explored the role of the hepatic B cell leukemia-3 (Bcl-3), a transcriptional regulator of nuclear factor-kappa B (NF-κB), in two independent models of ALF. We employed a recently developed transgenic mouse model in a C57BL6/J background comparing wild-type (WT) and transgenic littermates with hepatocyte-specific overexpression of Bcl-3 (Bcl-3(Hep)) in the ALF model of d-galactosamine (d-GalN) and lipopolysaccharide (LPS). Additionally, the apoptosis-inducing CD95 (FAS/APO-1)-ligand was explored. Bcl-3(Hep) mice exhibited a significant protection from ALF with decreased serum transaminases, decreased activation of the apoptotic caspases 8, 9, and 3, lower rates of oxidative stress, B-cell lymphoma 2 like 1 (BCL2L1/BCL-X(L)) degradation and accompanying mitochondrial cytochrome c release, and ultimately a decreased mortality rate from d-GalN/LPS compared to WT mice. d-GalN/LPS treatment resulted in a marked inflammatory cytokine release and stimulated the activation of signal transducer and activator of transcription (STAT) 3, c-Jun N-terminal kinases (JNK) and extracellular signal-regulated kinase (ERK) signaling comparably in the hepatic compartment of Bcl-3(Hep) and WT mice. However, in contrast to the WT, Bcl-3(Hep) mice showed a diminished rate of IkappaB kinase-beta (IKK-β) degradation, persistent receptor interacting protein kinase (RIPK) 1 function and thus prolonged cytoprotective nuclear factor-kappa B (NF-κB) p65 signaling through increased p65 stability and enhanced transcription. Likewise, Bcl-3 overexpression in hepatocytes protected from ALF with massive hepatocyte apoptosis induced by the anti-FAS antibody Jo2. The protection was also linked to IKK-β stabilization. Overall, our study showed that Bcl-3 rendered hepatocytes more resistant to hepatotoxicity induced by d-GalN/LPS and FAS-ligand. Therefore, Bcl-3 appears to be a critical regulator of the dynamics in ALF through IKK-β. Nature Publishing Group UK 2022-05-31 /pmc/articles/PMC9156769/ /pubmed/35641486 http://dx.doi.org/10.1038/s41419-022-04946-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Gehrke, Nadine
Wörns, Marcus A.
Mann, Amrit
Hövelmeyer, Nadine
Waisman, Ari
Straub, Beate K.
Galle, Peter R.
Schattenberg, Jörn M.
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title_full Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title_fullStr Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title_full_unstemmed Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title_short Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
title_sort hepatocyte bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156769/
https://www.ncbi.nlm.nih.gov/pubmed/35641486
http://dx.doi.org/10.1038/s41419-022-04946-y
work_keys_str_mv AT gehrkenadine hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT wornsmarcusa hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT mannamrit hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT hovelmeyernadine hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT waismanari hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT straubbeatek hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT gallepeterr hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure
AT schattenbergjornm hepatocytebcl3protectsfromdeathreceptormediatedapoptosisandsubsequentacuteliverfailure